Don’t hesitate to contact us today! 618-391-7030

spravato logo
bnr spravato

Spravato

Spravato® Treatment for Depression

FDA-Approved Relief for Treatment-Resistant Depression

Book a Spravato Consultation

What is SPRAVATO®?

SPRAVATO® is the only FDA-approved nasal spray for adults with treatment-resistant depression, used alone or alongside an oral antidepressant.

It may help relieve symptoms of depression when other antidepressants have not been effective

spravato
nasal spray

SPRAVATO® is the only FDA-approved nasal spray for treatment-resistant depression.

It is an NMDA (N-methyl-D-aspartate) receptor antagonist that may work differently from traditional antidepressants by targeting glutamate.

  • The exact way it works is not fully understood.

Glutamate is a chemical messenger in the brain believed to play a role in mood regulation, though its exact role in depression remains unclear.

Limitations of Use:

  • Not intended for pain relief or use as an anesthetic.
  • Safety and effectiveness as an anesthetic are unknown.
  • Not proven to prevent suicide or reduce suicidal thoughts or actions.
  • Not a substitute for hospitalization when deemed necessary by a healthcare provider, even if symptoms improve after the first dose.
  • Safety and effectiveness in children have not been established.

Understanding Spravato® Treatment

Learn how SPRAVATO® works and how treatment is provided.

Patient Testimonials

Nicole's Story

Allison's Story

Grace's Story

Ben's Story

Sally's Story

Amy's Story

Who Can Benefit from SPRAVATO®?

SPRAVATO® is approved for use in:

  • Adults living with treatment-resistant depression (TRD)
  • Adults diagnosed with major depressive disorder who are experiencing suicidal thoughts or behaviors

What is TRD?

Treatment-resistant depression occurs when symptoms do not improve after trying at least two different antidepressant medications at the right dose and duration.

Research shows that about 30% of people with depression meet the criteria for TRD.

Your SPRAVATO® Treatment Experience

At Innovative Women’s Healthcare, an FDA REMS-Certified Treatment Center, patients receive SPRAVATO® in a safe, comfortable, and closely monitored environment. Each session is conducted in-office under the supervision of a trained healthcare provider and followed by an observation period to ensure safety and comfort.

The SPRAVATO® Treatment Process

Before Treatment

  • Initial evaluation and medical review
  • Discussion of treatment goals and process
spravato
spravato

During Treatment

  • SPRAVATO® nasal spray administration in-office
  • Monitored observation period after each dose

After Treatment

  • Ongoing follow-ups to monitor progress and adjust care
spravato

Why Choose Us

Certified Spravato Treatment Center

Our team is fully trained and certified to administer Spravato safely and effectively.

Insurance Coordination and Prior Authorization Assistance

We manage all insurance documentation and approval processes on your behalf.

Safe, Comfortable Clinical Environment

Enjoy private treatment rooms with continuous monitoring for your safety and comfort.

Skilled and Experienced Providers

Our specialists have extensive expertise in treatment-resistant depression and ketamine-based therapies.

Ready to take the first step toward a better you?

Book a Spravato Consultation

Resources & Patient Education

We’ve made it easy to access official SPRAVATO® materials to help you learn more about treatment:

Patient Onboarding Brochure

pdf

Spravato® Prescribing Information

pdf

Spravato® Medication Guide

pdf

Patient Referral for SPRAVATO® Treatment

pdf

Patient Treatment Progress Form

pdf

Spravato® Patient Brochure

pdf